Close Menu
Home » BostonGene Partners With NIH on Clonal Evolution Study

BostonGene Partners With NIH on Clonal Evolution Study

Jul 23, 2019
|
Andrew P. Han

NEW YORK – BostonGene today announced a partnership with the National Institutes of Health to offer molecular profiling and therapy recommendations in a cancer study.

The software firm is launching a new study with collaborators at the National Cancer Institute and the National Institute of Allergy and Infectious Disease to analyze the clonal evolution of solid and liquid tumors in patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Aug
28
Featured Webinar

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases

Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Sep
18
Featured Webinar

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care

Sponsored by
Bionano Genomics

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Oct
03
Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

Sponsored by
Agilent

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

What's Popular?

In Cancer

  1. USPSTF Formalizes Slightly Expanded BRCA Screening Recommendations

  2. Cancer Genetics Posts 15 Percent Rise in Q2 Revenues

  3. Canaccord Genuity, SVB Leerink Initiate Coverage of Castle Biosciences

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.